New ScientistAnti-doping agency to ban all gene editing in sport from 2018New ScientistWADA already bans the use of genetically modified cells and gene therapy if they have “the potential to enhance sport performance”. From 2018, the list will also inc… Continue reading
ForbesHave Advancements Brought On The Age Of Gene Therapy?ForbesThe field of genetic engineering took a bold step forward this year when the first cell-based gene therapy to treat acute lymphoblastic leukemia was approved in the United States by the … Continue reading
DailyCommerceNewsInternational Stem Cell Corporation Developed 3D Bioprinting Technology Targeted to Treat Liver DiseasesMarkets InsiderCARLSBAD, Calif., Oct. 09, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (www.internatio… Continue reading
DailyCommerceNewsInternational Stem Cell Corporation Developed 3D Bioprinting Technology Targeted to Treat Liver DiseasesNasdaqCARLSBAD, Calif., Oct. 09, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemce… Continue reading
International Stem Cell Corporation Developed 3D Bioprinting Technology Targeted to Treat Liver DiseasesGlobeNewswire (press release)CARLSBAD, Calif., Oct. 09, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (www.international… Continue reading
|
‘CRISPR-Gold’ repairs muscular dystrophy gene in mouse model
BioNews Scientists have repaired the faulty gene in a mouse model of muscular dystrophy by using gold nanoparticles to deliver the genome editing tool CRISPR/Cas9. The new system, termed CRISPR-Gold, overcomes some issues associated with viral vectors, … |
|
‘CRISPR-Gold’ repairs muscular dystrophy gene in mouse model
BioNews Scientists have repaired the faulty gene in a mouse model of muscular dystrophy by using gold nanoparticles to deliver the genome editing tool CRISPR/Cas9. The new system, termed CRISPR-Gold, overcomes some issues associated with viral vectors, … |
|
Aduro Biotech Announces Upcoming Data Presentations at the Society for Immunotherapy of Cancer’s 32nd Annual …
Markets Insider BERKELEY, Calif., Oct. 09, 2017 (GLOBE NEWSWIRE) — Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, today announced data presentations relating to its technology platforms to be given … |